

Can't find or afford Striverdi Respimat? Explore real COPD inhaler alternatives like Arcapta, Serevent, and Stiolto with this patient-friendly guide.
If you've been prescribed Striverdi Respimat (Olodaterol) for your COPD and can't fill your prescription — whether it's out of stock, too expensive, or not covered by your insurance — it's natural to feel worried. After all, your breathing depends on it.
But here's the reassuring truth: Striverdi is not the only maintenance inhaler for COPD. There are several alternatives in the same drug class that your doctor may be able to prescribe instead. In this article, we'll cover what Striverdi does, how it works, and the most common alternatives available in 2026.
Striverdi Respimat is a brand-name inhaler containing Olodaterol, a long-acting beta2-adrenergic agonist (LABA). It's prescribed for the long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.
It's manufactured by Boehringer Ingelheim and delivered through the Respimat soft mist inhaler device. The standard dose is two inhalations (5 mcg total) once daily at the same time each day.
For more details on Striverdi, check out our full guide: What is Striverdi? Uses, dosage, and what you need to know.
Striverdi belongs to a class of drugs called long-acting beta2-adrenergic agonists (LABAs). These medications work by binding to beta2 receptors in the smooth muscle of your airways. When these receptors are activated, the muscles relax, and the airways widen — a process called bronchodilation.
Unlike short-acting rescue inhalers (like Albuterol), which work quickly but wear off in a few hours, Striverdi provides sustained bronchodilation for 24 hours. That's why it's classified as an "ultra-LABA" — it only needs to be taken once a day.
For a deeper dive into the science, read our article on how Striverdi works: mechanism of action explained.
If you can't get Striverdi, there are several other COPD maintenance inhalers your doctor may consider. Here are the most common alternatives:
Arcapta Neohaler is another once-daily LABA inhaler approved for the maintenance treatment of COPD. Like Striverdi, it provides 24-hour bronchodilation with a single daily dose.
Serevent Diskus is a twice-daily LABA delivered through a dry powder diskus device. It's been on the market longer than Striverdi and is widely available.
Perforomist is a twice-daily LABA delivered via nebulizer. It's a good option for patients who have difficulty using handheld inhalers.
Stiolto Respimat is a combination inhaler that contains Olodaterol (the same active ingredient in Striverdi) plus Tiotropium (a long-acting muscarinic antagonist, or LAMA). It's a once-daily inhaler for COPD.
If you're considering an alternative to Striverdi, here's how to have a productive conversation with your doctor:
If you'd prefer to stay on Striverdi, it may still be available at a pharmacy near you. Use Medfinder to search for pharmacies with Striverdi in stock, or read our guide on how to find Striverdi in stock near you.
You can also explore savings options if cost is the issue. Our article on how to save money on Striverdi covers coupons, discount cards, and patient assistance programs that could bring your cost down significantly.
Not being able to fill your Striverdi prescription can be stressful, but you're not without options. Several other COPD maintenance inhalers work in similar ways, and your doctor can help you find the one that fits your needs, your budget, and your lifestyle. Whether you switch to an alternative or find Striverdi at another pharmacy, the most important thing is staying on your treatment plan.
Don't let a stocking issue or a formulary change derail your breathing. Talk to your doctor, explore your options, and use tools like Medfinder to stay in control.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.